Abstract
The purpose of this study is to report a case of disseminated histoplasmosis in a patient with uveitis, after treatment with infliximab. The method employed in this study is single case report. Infliximab can be useful in controlling idiopathic uveitis, but can give rise to disseminated histoplamosis, especially in patients living in geographic areas where histoplasmosis is endemic. Clinicians should be aware of the possibility of rapid onset histoplasmosis in patients receiving anti-tumor necrosis factor agents. In such cases, these agents should be immediately stopped, investigations performed, and appropriate treatment started.
References
Khanna D, McMahon M, Furst DE (2004) Anti-tumor necrosis factor alpha therapy and heart failure: what have we learned and where do we go from here? Arthr Rheum 50:1040–1050
Okada AA, Sakai J, Usui M, Mizuguchi J (1998) Intraocular cytokine quantification of experimental autoimmune uveoretinitis in rats. Ocul Immunol Inflamm 6:111–120
Lee J-H, Slifman NR, Gershon SK et al (2002) Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factors alpha antagonists infliximab and etanercept. Arthr Rheum 46:2565–2570
Keane J, Gershon S, Wise RP et al (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345:1098–1104
Rajaraman RT, Kimura Y, Li S, Haines K, Chu DS (2006) Retrospective case review of pediatric patients with uveitis treated with infliximab. Ophthalmology 113:308–314
Allendoerfer R, Deepe GS Jr (1997) Intrapulmonary response to histoplasma capsulatum in gamma interferon knockout mice. Infect Immun 65(7):2564–2569
Wood KL, Hage CA et al (2003) Histoplasmosis after treatment with anti-TNF-alpha therapy. Am J Respir Crit Care Med 167(9):1279–1282
Conflict of interest
All authors declare no conflict of interest and no financial or proprietary interest in the writing of this article. This article received no funding.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lim, L.T., Ruzmetova, N., Ballinger, S.H. et al. Acute pulmonary histoplasmosis in a patient with uveitis after infliximab therapy. Int Ophthalmol 31, 349–351 (2011). https://doi.org/10.1007/s10792-011-9459-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-011-9459-3